Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 17.50 as of Tuesday, July 28, 2026.
Forward PE Ratio (17.50) = Close Price ($319.58) / Consensus Forward EPS ($17.78)
FORWARD PE RATIO
17.50
SECTOR MEDIAN · HEALTHCARE
18.59
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-5.89%
vs the sector median at left
Cencora, Inc.
Market Cap
$62.18B
Forward PE Ratio
17.50
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cencora, Inc. (COR) | $62.18B | 17.50 |
| Becton, Dickinson and Company (BDX)vs › | $60.26B | 12.60 |
| Boston Scientific Corporation (BSX)vs › | $68.46B | 13.56 |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 21.28 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $71.62B | 14.58 |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 27.66 |
| Humana Inc. (HUM)vs › | $46.67B | 42.42 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 37.97 |
| Cigna Corporation (CI)vs › | $79.64B | 9.55 |
| Elevance Health Inc. (ELV)vs › | $83.65B | 13.95 |
Trailing P/E
23.9
reported TTM EPS
Forward P/E
17.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $17.78 implies +36.3% EPS growth vs the reported trailing $13.04.
At today's $319.58 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| Fiscal year end |
|---|
| Consensus EPS |
|---|
| Estimate range |
|---|
| Analysts |
|---|
| Implied P/E |
|---|
| 2026-09-30 | $17.78 | $17.76 – $17.82 | 7 | 18.0x |
| 2027-09-30 | $19.82 | $19.63 – $20.15 | 8 | 16.1x |
| 2028-09-30 | $22.04 | $20.13 – $24.67 | 3 | 14.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
